Tiragolumab| ChemScene
Tiragolumab is an immune checkpoint inhibitor binding to T-cell immunoglobulin and ITIM domain (TIGIT). Tiragolumab, alone or in combination with the PD-L1 inhibitor Atezolizumab, may be effective against multiple solid malignancies-most notably non-small cell lung cancer[2].
Trivial name | Tiragolumab |
Catalog Number | CS-0373621 |
Molecular Formula | 1000 |
CAS# | 1918185-84-8 |
Purity | >98% |
Condensed Formula | N/A |
Size | 1mg |
Supplier Page | www.chemscene.com/1918185-84-8.html |